FDA Drug · D-0018-2027

SEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936

Class II · Ongoing

Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.

Affected lots / codes — check yours against thisLot: 08262026@6, BUD:10/10/2026.

Recalling firm: Carolina Infusion, LLC, Ridgeland, SC
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 8 x 0.1 ml syringes
Distribution: Nationwide within the U.S
Recall initiated: September 10, 2026
Classified: October 8, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0018-2027%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →